J Ostergren

Summary

Affiliation: Karolinska Hospital
Country: Sweden

Publications

  1. ncbi request reprint Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease
    J Ostergren
    Department of Medicine, Division of Emergency Medicine, Karolinska Hospital, 171 76 Stockholm, Sweden
    Eur Heart J 25:17-24. 2004
  2. ncbi request reprint Episodes of ST-segment depression is related to changes in ambulatory blood pressure and heart rate in intermittent claudication
    P Svensson
    Department of Medicine, Karolinska Hospital, Stockholm, Sweden
    J Intern Med 250:398-405. 2001
  3. ncbi request reprint Asymptomatic versus symptomatic persistent atrial fibrillation: clinical and noninvasive characteristics
    V Frykman
    Department of Cardiology, Karolinska Hospital, Karolinska Institute, Stockholm, Sweden
    J Intern Med 250:390-7. 2001
  4. ncbi request reprint Effect of amlodipine versus felodipine extended release on 24-hour ambulatory blood pressure in hypertension
    J Ostergren
    Department of Medicine, Karolinska Hospital, Stockholm, Sweden
    Am J Hypertens 11:690-6. 1998
  5. doi request reprint Cystatin C--a marker of peripheral atherosclerotic disease?
    J Arpegård
    Department of Medicine, Division of Emergency Medicine, Karolinska University Hospital Solna, Stockholm, Sweden
    Atherosclerosis 199:397-401. 2008
  6. ncbi request reprint Office blood pressure underestimates ambulatory blood pressure in peripheral arterial disease in comparison to healthy controls
    P Svensson
    Department of Cardiology, Karolinska Hospital, Sweden
    J Hum Hypertens 18:193-200. 2004
  7. ncbi request reprint Is there a need for the medical angiologist?
    J Ostergren
    Department of Medicine, Karolinska Hospital, Stockholm, Sweden
    Eur J Vasc Endovasc Surg 24:4-5. 2002
  8. ncbi request reprint The cost-effectiveness of ramipril in the treatment of patients at high risk of cardiovascular events: a Swedish sub-study to the HOPE study
    I Björholt
    Department of Health Economics, AstraZeneca Sverige AB, Molndal, Sweden
    J Intern Med 251:508-17. 2002
  9. ncbi request reprint Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme
    J McMurray
    Department of Cardiology, Western Infirmary, University of Glasgow, Glasgow G11 6NT, Scotland, UK
    Eur J Heart Fail 5:261-70. 2003
  10. ncbi request reprint What is the relevance of the HOPE study in general practice?
    J Kennedy
    Medical Department M Diabetes and Endocrinology, Aarhus Kommunehospital, Denmark
    Int J Clin Pract 55:449-57. 2001

Collaborators

Detail Information

Publications10

  1. ncbi request reprint Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease
    J Ostergren
    Department of Medicine, Division of Emergency Medicine, Karolinska Hospital, 171 76 Stockholm, Sweden
    Eur Heart J 25:17-24. 2004
    ....
  2. ncbi request reprint Episodes of ST-segment depression is related to changes in ambulatory blood pressure and heart rate in intermittent claudication
    P Svensson
    Department of Medicine, Karolinska Hospital, Stockholm, Sweden
    J Intern Med 250:398-405. 2001
    ....
  3. ncbi request reprint Asymptomatic versus symptomatic persistent atrial fibrillation: clinical and noninvasive characteristics
    V Frykman
    Department of Cardiology, Karolinska Hospital, Karolinska Institute, Stockholm, Sweden
    J Intern Med 250:390-7. 2001
    ..This prospective study was designed to investigate the differences between asymptomatic versus symptomatic arrhythmia as well as left ventricular dysfunction in a consecutive population of patients with persistent atrial fibrillation...
  4. ncbi request reprint Effect of amlodipine versus felodipine extended release on 24-hour ambulatory blood pressure in hypertension
    J Ostergren
    Department of Medicine, Karolinska Hospital, Stockholm, Sweden
    Am J Hypertens 11:690-6. 1998
    ..The longer elimination half-life of amlodipine as compared to felodipine is the probable reason for this finding...
  5. doi request reprint Cystatin C--a marker of peripheral atherosclerotic disease?
    J Arpegård
    Department of Medicine, Division of Emergency Medicine, Karolinska University Hospital Solna, Stockholm, Sweden
    Atherosclerosis 199:397-401. 2008
    ..However, studies on this topic are few and results have been indecisive. Our aim was to further investigate the subject of Cystatin C as an independent marker of peripheral atherosclerotic disease...
  6. ncbi request reprint Office blood pressure underestimates ambulatory blood pressure in peripheral arterial disease in comparison to healthy controls
    P Svensson
    Department of Cardiology, Karolinska Hospital, Sweden
    J Hum Hypertens 18:193-200. 2004
    ..Night SBP was higher only in patients with antihypertensive treatment. In PAD patients, especially when on antihypertensive treatment, the severity of hypertension may be underestimated when based on OBP only...
  7. ncbi request reprint Is there a need for the medical angiologist?
    J Ostergren
    Department of Medicine, Karolinska Hospital, Stockholm, Sweden
    Eur J Vasc Endovasc Surg 24:4-5. 2002
  8. ncbi request reprint The cost-effectiveness of ramipril in the treatment of patients at high risk of cardiovascular events: a Swedish sub-study to the HOPE study
    I Björholt
    Department of Health Economics, AstraZeneca Sverige AB, Molndal, Sweden
    J Intern Med 251:508-17. 2002
    ..To evaluate if long-term treatment with ramipril is cost-effective in patients at high risk of cardiovascular events...
  9. ncbi request reprint Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) programme
    J McMurray
    Department of Cardiology, Western Infirmary, University of Glasgow, Glasgow G11 6NT, Scotland, UK
    Eur J Heart Fail 5:261-70. 2003
    ....
  10. ncbi request reprint What is the relevance of the HOPE study in general practice?
    J Kennedy
    Medical Department M Diabetes and Endocrinology, Aarhus Kommunehospital, Denmark
    Int J Clin Pract 55:449-57. 2001
    ..The effectiveness of therapy should also be regularly reviewed and dose adjustments made where necessary. If concern remains, referral to a specialist--a cardiologist or a diabetologist--may ultimately be necessary...